Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lohmann Animal Health was a prominent global provider of poultry vaccines and feed additives, serving the livestock industry with a specialized focus on avian health. Headquartered in Cuxhaven, Germany, with its U.S. operations based in Winslow, Maine, the company was widely recognized for its AviPro line of vaccines and its expertise in preventing infectious diseases in poultry. In 2014, the company was acquired by Elanco, the animal health division of Eli Lilly and Company, for approximately $535 million. The acquisition significantly bolstered Elanco's position in the global poultry market and expanded its vaccine manufacturing capabilities, with Lohmann's products now fully integrated into the Elanco portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lohmann Animal Health International.